Active Biotech AB publ
STO:ACTI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Active Biotech AB publ
Operating Income
Active Biotech AB publ
Operating Income Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
A
|
Active Biotech AB publ
STO:ACTI
|
Operating Income
-kr37.6m
|
CAGR 3-Years
13%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
14%
|
|
|
Biogaia AB
STO:BIOG B
|
Operating Income
kr452m
|
CAGR 3-Years
11%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
|
|
Bonesupport Holding AB
STO:BONEX
|
Operating Income
kr171.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Vitrolife AB
STO:VITR
|
Operating Income
kr574m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
9%
|
CAGR 10-Years
10%
|
|
|
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
|
Operating Income
kr8.1B
|
CAGR 3-Years
21%
|
CAGR 5-Years
13%
|
CAGR 10-Years
49%
|
|
|
BioArctic AB
STO:BIOA B
|
Operating Income
kr1.3B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Active Biotech AB publ
Glance View
Active Biotech AB engages in the development of pharmaceutical products. The company is headquartered in Lund, Skane. The project portfolio comprises both small, orally active immunomodulatory molecules and antibody-based immunotherapy.
See Also
What is Active Biotech AB publ's Operating Income?
Operating Income
-37.6m
SEK
Based on the financial report for Dec 31, 2025, Active Biotech AB publ's Operating Income amounts to -37.6m SEK.
What is Active Biotech AB publ's Operating Income growth rate?
Operating Income CAGR 10Y
14%
Over the last year, the Operating Income growth was 6%. The average annual Operating Income growth rates for Active Biotech AB publ have been 13% over the past three years , -3% over the past five years , and 14% over the past ten years .
